Direct Interaction of Endothelial Nitric-oxide Synthase and Caveolin-1 Inhibits Synthase Activity
Overview
Authors
Affiliations
Endothelial nitric-oxide synthase (eNOS) and caveolin-1 are associated within endothelial plasmalemmal caveolae. It is not known, however, whether eNOS and caveolin-1 interact directly or indirectly or whether the interaction affects eNOS activity. To answer these questions, we have cloned the bovine caveolin-1 cDNA and have investigated the eNOS-caveolin-1 interaction in an in vitro binding assay system using glutathione S-transferase (GST)-caveolin-1 fusion proteins and baculovirus-expressed bovine eNOS. We have also mapped the domains involved in the interaction using an in vivo yeast two-hybrid system. Results obtained using both in vitro and in vivo protein interaction assays show that both N- and C-terminal cytosolic domains of caveolin-1 interact directly with the eNOS oxygenase domain. Interaction of eNOS with GST-caveolin-1 fusion proteins significantly inhibits enzyme catalytic activity. A synthetic peptide corresponding to caveolin-1 residues 82-101 also potently and reversibly inhibits eNOS activity by interfering with the interaction of the enzyme with Ca2+/calmodulin (CaM). Regulation of eNOS in endothelial cells, therefore, may involve not only positive allosteric regulation by Ca2+/CaM, but also negative allosteric regulation by caveolin-1.
Promotion of nitric oxide production: mechanisms, strategies, and possibilities.
Gonzalez M, Clayton S, Wauson E, Christian D, Tran Q Front Physiol. 2025; 16:1545044.
PMID: 39917079 PMC: 11799299. DOI: 10.3389/fphys.2025.1545044.
Curry-Koski T, Gusek B, Potter R, Jones T, Dickman R, Johnson N Int J Mol Sci. 2024; 25(23).
PMID: 39684412 PMC: 11641669. DOI: 10.3390/ijms252312702.
The Adhesion GPCR ADGRL2/LPHN2 Can Protect Against Cellular and Organismal Dysfunction.
Jakobs P, Rafflenbeul A, Post W, Ale-Agha N, Gross V, Pick S Cells. 2024; 13(22).
PMID: 39594576 PMC: 11592504. DOI: 10.3390/cells13221826.
Interplay between caveolin-1 and mineralocorticoid receptor in cardiometabolic disease.
Czarzasta K, Pojoga L J Endocrinol. 2024; 262(3).
PMID: 38916410 PMC: 11813230. DOI: 10.1530/JOE-23-0341.
Scaffolds and the scaffolding domain: an alternative paradigm for caveolin-1 signaling.
Lim J, Bernatchez P, Nabi I Biochem Soc Trans. 2024; 52(2):947-959.
PMID: 38526159 PMC: 11088920. DOI: 10.1042/BST20231570.